Skip to main content

Table 4 Clinical outcome of patients

From: The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis [ISRCTN28863830]

Criterion

Pentaglobin® group

Control group

P

Septic shock incidence (%)

8/21 (38)

12/21 (57)

0.35

Duration of mechanical ventilation (days)

20 (2–58)

19 (2–76)

0.60

ICU length of stay (days)

29 (3–89)

22 (3–85)

0.35

28-day mortality (%)

5/21 (23.8)

7/21 (33.3)

0.70

  1. Values are expresed as median (range). Pentaglobin® group (n = 21); control group (n = 21). ICU, intensive care unit.